Overview

Albuterol and Immune Cell Composition

Status:
Withdrawn

Trial end date:
2021-06-20

Target enrollment:

Participant gender:

Summary

The aim of this pilot study is to determine the effects of albuterol on the composition of immune cells in the bloodstream for possible future use in patients with neuroblastoma.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Arizona

Treatments:

Albuterol